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Abstract: Type A procyanidins can be synthesized in good yields from the condensation of 
benzopyrilium salts 8 and either catechin or phloroglucinol. 
 




The prevention and control of Type 2 diabetes is a major human healthcare objective. The 
pathogenesis of this disease has been studied by several researchers [1].  Diet has been shown to play a 
definite role in the onset of Type 2 diabetes, and the foods typically consumed in the United States 
appear to increase the incidence of diabetes [2].  A Finnish study showed that Type 2 diabetes could be 
prevented by changes in the lifestyles of high-risk subjects [3]. Another recent study concluded that 
Type 2 diabetes could be prevented or delayed through lifestyle modifications or through 
pharmacologic interventions [4]. The relatively high sugar and fat content of American diets is likely 
to increase the incidence of diabetes, but the low intake of traditional herbs, spices, and other plant 
products may also be a factor.   
Plants may not only be important for the control of Type 2 diabetes but also for its prevention, 
especially for people with elevated levels of blood glucose and glucose intolerance who have a greater 
risk of developing diabetes.  Common spices such as cinnamon, cloves, and bay leaves display insulin-
potentiating activity in vitro [5].  It was hypothesized that these spices might also have high chromium 
concentrations, because biologically active forms of chromium potentiate insulin activity. However, 
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there were no correlations between total chromium concentrations and insulin potentiating activity in 
these plant products.   
From an aqueous extract of commercial cinnamon, Anderson and coworkers have identified 
polyphenolic polymers that increase glucose metabolism roughly 20-fold in vitro in the epididymal fat 
cell assay [6].  Additionally, approximately 50 plant extracts have also been investigated in this assay, 
and none have shown activity equal to that of cinnamon [7]. 
Recently, Anderson and coworkers extracted cinnamon samples with acetic acid and ethanol and 
isolated fractions with insulin-enhancing activity using HPLC [8-10].  Spectral analysis indicated the 
presence of type A procyanidins.  The procyanidins encompass dimers, trimers and higher oligomers 
composed of catechin (1) and epicatechin (2). In procyanidins, the B series of compounds is 
characterized by one interflavanoid linkage (one C-C bond) and is exemplified by procyanidins B2 (3) 
and B3 (4). The A series of compounds contains two interflavanoid linkages (one C-C bond and one 
C-O bond). Procyanidins A1 (5) and A2 (6) are active compounds from this series. The C series 
consists of trimers of catechin or epicatechin and is represented by compound 7.   
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The fractions containing these A-type procyanidins were shown to have insulin-enhancing 
biological activity in an in vitro assay measuring the insulin-dependent effects on glucose metabolism 
[6]. These same compounds have been shown to inhibit phosphotyrosine phosphatases in the insulin-
receptor domain and to activate insulin receptor kinase, and to function as a mimetic for insulin in 
3T3-L1 adipocytes [11]. Water-soluble polymeric polyphenols from cinnamon have also been shown 
to inhibit cell proliferation and to alter cell cycle distribution patterns of hematologic tumor cell lines 
[12]. 
Results and Discussion 
Type A procyanidins are difficult to synthesize. Morimoto prepared procyanidins A in low yield by 
the oxidation of procyanidin B2 with hydrogen peroxide in the presence of sodium bicarbonate [13].  
Pomilo reacted a flavylium perchloride with (+)-catechin in aqueous methanol to yield a compound in 
only 2-3% yield [14].  Therefore, there is a continuing need for methods to prepare polyphenols such 
as those derived from cinnamon. Recently Pettus prepared a type A procyanidin (diinsininone) using 
microwave chemistry at 120 °C [15]. Our route to type A procyanidins is illustrated below in Scheme 
1. Although it utilizes starting materials similar to those used by Pomilo and by Morimoto, our 
optimized conditions provide dramatically improved yields [16].   
 



































The synthetic route shown in Scheme 1 permits the preparation of a variety of procyanidin 
structures. In this paper we will describe our synthesis of compounds of general structure 10, with X, 
Y and Z as either electron-donating or electron-withdrawing groups. The benzopyrilium salts 8 were 
generated in yields ranging from 70-90%  from the corresponding salicylaldehyde and acetophenone 
by a standard acid catalyzed cyclization. For example, the compound 8 wherein X and Y are hydroxyl 
groups and Z is a hydrogen was prepared in 85% yield by condensing salicylaldehyde and 3,4-
dihydroxyacetophenone [17]. The reaction of the benzopyrilium salts with 1 to produce 10 was 
conducted under anhydrous conditions in methanol at temperatures ranging from ambient temperature 
to 50 °C.  The results of our research are compiled below in Table 1. The products were mixtures of 
two diastereomers in ratios of 1.2:1 to 1.5:1. Molecular models show that the methine proton of the 
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benzylic ether (C-2 of catechin) in the minor isomer should be deshielded relative to the corresponding 
methine of the major isomer. However, the actual difference in chemical shifts is small and thus the 
structure assignments are tentative.  This is observed for 10A - 10F and is the basis for assignment of 
the structures of the diastereomers. As indicated by Table 1, a variety of substituent patterns are 
possible.  The only limitation we found was that substitution at position 5 in compound 8 dramatically 
reduced the rate of cyclization. The rationale for the improved yields is unclear and may reflect the 
importance of limiting the amount of water present during the reaction.   
 







X Y Z Yield (%) dr  10 
H H H 82 1.5 10A 
H OH H 79 1.2 10B 
H OH OH 89 1.5 10C 
NO2 OH H 83 1.5 10D 
NO2 OH OH 76 1.5 10E 
H OCH3 OCH3 83 1.2 10F 
 
The salts also reacted effectively with phloroglucinol (9). In this case only a single diastereomer 
could be formed. Compounds 11 and 12 were produced in 76% and 80% yields, respectively.   
 











11:  X = H




In summary, type A procyanidins 10 - 12 are readily synthesized from benzopyrilium salts 8 and 
either catechin or phloroglucinol. The experimental conditions are operationally convenient and the 
reaction can be scaled up to produce gram quantities of type A procyanidins.   
 
 






Unless stated otherwise, all reactions were magnetically stirred and monitored by thin-layer 
chromatography (TLC) using 0.25 mm precoated silica gel F254 plates (Sigma-Aldrich). Column or 
flash chromatography was performed with the indicated solvents using silica gel (230-400 mesh) 
purchased from Dynamic Adsorbents, LLC. All melting points were obtained on a Laboratory Devices 
capillary melting point apparatus and are uncorrected. 1H- and 13C-NMR spectra were recorded on a 
Bruker VXR-400 (400 MHz) spectrometer. Chemical shifts are reported relative to internal chloroform 
(1H, 7.26 ppm; 13C, 77.23 ppm). High resolution mass spectra were performed at the Iowa State 
University Mass Spectrometry Laboratory. 
 
General synthesis of type A procyanidins 10A-10F, 11 and 12 
 
To a solution of (+)-catechin hydrate (925 mg, 3.0 mmol) or phloroglucinol (378 mg, 3.0 mmol) in 
methanol (65 mL) was added flavylium salt (920 mg, 3.0 mmol) at room temperature (rt). The solution 
was stirred at rt for 15 h, concentrated and adsorbed on approximately a gram of silica gel. The crude 
product was purified by column chromatography on silica gel using hexanes-ethyl acetate-methanol 
(2:1:0 – 1:1.5:0.005) as eluent. Gram quantities of product were collected in yields ranging from 70-
89%. The products 10A-10F contain two stereoisomers in a ratio indicated by the proton NMR 
spectrum. Polar diastereomers were separated using silica gel preparative TLC using 10:1 ethyl acetate: 




2H,14H-8,14-methanochromeno[7,8-d][1,3]benzodioxocin-3,5-diol (10A). Yield 82%. Major isomer 
(60%). 1H-NMR (400 MHz, CD3OD) 7.70　 -7.61 (m, 2H), 7.42-7.31 (m, 3H), 7.14 (dd, J = 7.6, 1.6 
Hz, 1H), 7.10- 6.98 (m, 2H), 6.93-6.72 (m, 4H), 6.09 (s, 1H), 4.58 (d, J = 8.0 Hz, 1H), 4.33 (t, J = 3.0 
Hz, 1H), 4.02 (m, 1H), 2.95 (dd, J = 16.4, 5.6 Hz, 1H), 2.51 (dd, J = 16.4, 8.0 Hz, 1H), 2.22 (dd, J = 
13.2, 3.0 Hz, 1H), 2.18 (dd, J = 13.2, 3.0 Hz, 1H); 13C-NMR (100 MHz, CD3OD) 155.7, 153.7, 　
152.7, 152.0, 146.4, 146.3, 146.3, 143.3, 132.1, 129.6, 129.2, 129.1, 128.9, 128.6, 128.3, 126.7, 122.0, 
120.2, 116.8, 116.3, 115.5, 106.9, 102.8, 99.9, 96.3, 823.0, 68.7, 34.5, 29.3, 28.0; HRMS (EI) m/z 
496.1530 (M, 496.1522 calcd for C30H24O7); MS(EI) m/z 496 (11), 207 (100), 178 (39), 152 (58), 131 
(70). Minor isomer (40%). 1H-NMR (400 MHz, CD3OD)  7.70　 -7.61 (m, 2H), 7.42-7.31 (m, 3H), 
7.26 (dd, J = 7.6, 1.6 Hz, 1H), 7.10- 6.98 (m, 2H), 6.93-6.72 (m, 4H), 6.10 (s, 1H), 4.71 (d, J = 8.0 Hz, 
1H), 4.27 (t, J = 3.0 Hz, 1H), 3.96 (m, 1H), 2.87 (dd, J = 16.4, 5.6 Hz, 1H), 2.55 (dd, J = 16.4, 8.0 Hz, 
1H), 2.16 (dd, J = 13.2, 3.0 Hz, 1H), 2.10 (dd, J = 13.2, 3.0 Hz, 1H); 13C-NMR (100 MHz, CD3OD)  　
155.8, 153.6, 152.5, 152.0, 146.4, 146.3, 146.3, 143.3, 132.2, 129.6, 129.2, 129.1, 128.9, 128.6, 128.4, 
126.7, 122.0, 120.4, 116.8, 116.0, 115.5, 106.8, 102.5, 99.9, 96.2, 83.5, 68.8, 34.6, 28.6, 27.9. 
 





hydroxyphenyl)-3,4-dihydro-2H,14H-8,14 methanochromeno [7,8d][1,3] benzodioxocin-3,5-diol (10B) 
Yield 78%.  Major isomer (55%): 1H-NMR (400 MHz, CD3OD)  7.54　 -7.48 (m, 2H), 7.12 (d, J = 7.2 
Hz, 1H), 7.09 - 6.70 (m, 8H), 6.11 (s, 1H), 4.59 (d, J = 8.4 Hz, 1H), 4.35 (t, J = 3.0 Hz, 1H), 3.98 (m, 
1H), 3.01 (dd, J = 16.4, 5.6 Hz, 1H), 2.52 (dd, J = 16.4, 8.4 Hz, 1H), 2.25 (dd, J = 13.2, 3.0 Hz, 1H), 
2.16 (dd, J = 13.2, 3.0 Hz, 1H). Minor isomer (45%): 1H NMR (400 MHz, CD3OD)  7.54　 -7.48 (m, 
2H), 7.27(d, J = 7.2 Hz, 1H), 7.09-6.70 (m, 8H), 6.12 (s, 1H), 4.71 (d, J = 8.4 Hz, 1H), 4.31 (t, J = 3.0 
Hz, 1H), 4.04 (m, 1H), 2.92 (dd, J = 16.4, 5.6 Hz, 1H), 2.57 (dd, J = 16.4, 8.4 Hz, 1H), 2.19 (dd, J = 





diol (10C).  Yield 89%.  Major isomer (60%): 1H-NMR (400 MHz, CD3CN)  7.50　 -6.75 (m, 10H), 
6.09 (s, 1H), 4.64 (d, J = 8.0 Hz, 1H), 4.33 (br, 1H), 4.06 – 3.92 (m, 1H), 2.93 – 2.72 (m, 1H), 2.57 – 
2.42 (m, 1H), 2.32 – 2.08 (m, 2H). Minor isomer (40%): 1H-NMR (400 MHz, CD3CN)  7.50 　 -6.75 
(m, 10H), 6.10 (s, 1H), 4.73 (d, J = 8.0 Hz, 1H), 4.25 (br, 1H), 4.06 – 3.92 (m, 1H), 2.93 – 2.72 (m, 





3,5-diol (10D). Yield 83%.  Major isomer (60%): 1H-NMR (400 MHz, CD3OD)  7.99 (d, 　 J = 2.8 Hz, 
1H), 7.77 (dd, J = 8.8, 2.8 Hz, 1H), 7.52-7.40 (m, 2H), 7.08-6.78 (m, 6H), 6.07 (s, 1H), 4.59 (d, J = 8.0 
Hz, 1H), 4.34 (t, J = 2.8 Hz, 1H), 4.11 (ddd, J = 16.4, 8.0, 5.6 Hz, 1H), 2.95 (dd, J = 16.4, 5.6 Hz, 1H), 
2.49 (dd, J = 16.4, 8.4 Hz, 1H), 2.26-2.01(m, 2H); 13C-NMR (100 MHz, CD3OD)  159.3, 158.9, 　
152.7, 151.5, 146.4, 146.2, 142.4, 133.1, 131.5, 130.0, 127.1, 124.6, 124.4, 124.2, 124.1, 121.1, 117.3, 
119.6, 116.4, 115.9, 115.5, 105.6, 103.1, 100.9, 96.3, 83.0, 68.1, 33.3, 29.1, 27.9. Minor isomer (40%): 
1H-NMR (400 MHz, CD3OD)  8.14 (d, 　 J = 2.8 Hz, 1H), 7.84 (dd, J = 8.8, 2.8 Hz, 1H), 7.52-7.40 (m, 
2H), 7.08-6.78 (m, 6H), 6.07 (s, 1H), 4.68 (d, J = 8.0 Hz, 1H), 4.27 (t, J = 2.8 Hz, 1H), 3.94 (ddd, J = 
16.4, 8.0, 5.6 Hz, 1H), 2.88 (dd, J = 16.4, 5.6 Hz, 1H), 2.54 (dd, J = 16.4, 8.4 Hz, 1H), 2.26-2.01(m, 
2H); 13C-NMR (100 MHz, CD3OD)  159.4, 158.9, 156.1, 152.5, 151.5, 146.2, 145.9, 142.4, 133.1, 　
131.0, 129.8, 127.1, 124.6, 124.4, 124.1, 119.6, 121.1, 117.4, 116.8, 116.3, 115.9, 105.4, 103.0, 100.9, 




dihydro-2H,14H-8,14-methanochromeno[7,8-d][1,3]benzodioxocin-3,5-diol (10E). Yield 76%.  Major 
isomer (60%): 1H-NMR (400 MHz, CD3OD)  8.01 (br, 1H), 7.94 (dd, 　 J = 8.8, 2.0 Hz, 1H), 7.18-
6.78 (m, 7H), 6.09 (s, 1H), 4.61 (d, J = 7.6 Hz, 1H), 4.37 (br, 1H), 4.14 (m, 1H), 2.95 (dd, J = 16.4, 5.2 
Hz, 1H), 2.51 (dd, J = 16.4, 8.4 Hz, 1H), 2.32-2.06(m, 2H); 13C-NMR (100 MHz, CD3OD)  159.4, 　
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156.2, 152.7, 151.5, 146.8, 146.2, 145.9, 142.5, 133.8, 131.5, 130.1, 124.4, 124.3, 121.0, 118.2, 117.3, 
116.8, 116.4, 116.2, 115.9, 115.4, 114.1, 105.6, 103.1, 100.8, 83.5, 68.1, 33.5, 29.1, 27.9. Minor 
isomer (40%): 1H-NMR (400 MHz, CD3OD)  8.16 (br, 1H)　 , 7.91 (dd, J = 8.8, 2.0 Hz, 1H), 7.18-
6.78 (m, 7H), 6.09 (s, 1H), 4.70 (d, J = 7.6 Hz, 1H), 4.32 (br, 1H), 3.95 (m, 1H), 2.89(dd, J = 16.4, 5.2 
Hz, 1H), 2.55 (dd, J = 16.4, 8.4 Hz, 1H), 2.32-2.06(m, 2H); 13C-NMR (100 MHz, CD3OD)  159.5, 　
156.2, 152.5, 151.5, 146.4, 146.2, 145.9, 142.4, 133.8, 131.9, 129.9, 124.6, 124.1, 119.5, 118.3, 117.4, 





diol: (10F). Yield 83%. Major isomer (55%): 1H-NMR (400 MHz, CD3COCD3)  7.38　 -6.74 (m, 
10H), 6.16 (s, 1H), 4.62 (d, J = 8.0 Hz, 1H), 4.38 (t, J = 3.0 Hz, 1H), 4.13 (m, 1H), 3.85(m, 3H), 
3.83(m, 3H), 3.03 (dd, J = 16.4, 5.6 Hz, 1H), 2.57 (dd, J = 16.4, 8.0 Hz, 1H), 2.34 (dd, J = 13.6, 3.0 Hz, 
1H), 2.25 (dd, J = 13.6, 3.0 Hz, 1H); 13C-NMR (100 MHz, CD3COCD3)  156.2, 154.3, 153.4, 152.7, 　
150.9, 146.8, 146.6, 146.5, 133.1, 132.8, 129.2, 129.0, 122.6, 121.2, 120.0, 116.9, 116.3, 116.1, 113.1, 
107.6, 103.6, 100.4, 97.1, 83.7, 69.3, 57.2, 57.1, 34.9, 29.9, 28.5. Minor isomer (45%): 1H-NMR (400 
MHz, CD3COCD3)  7.38　 -6.74 (m, 10H), 6.18 (s, 1H), 4.73 (d, J = 8.0 Hz, 1H), 4.30 (t, J = 3.0 Hz, 
1H), 4.01 (m, 1H), 3.84(m, 3H), 3.83(m, 3H), 2.97 (dd, J = 16.4, 5.2 Hz, 1H), 2.61 (dd, J = 16.4, 8.0 
Hz, 1H), 2.28 (dd, J = 13.6, 3.0 Hz, 1H), 2.22 (dd, J = 13.6, 3.0 Hz, 1H); 13C-NMR (100 MHz, 
CD3COCD3)  156.2, 154.3, 153.2, 152.7, 151.5, 146.8, 146.7, 140.5, 133.0, 129.7, 129.5, 129.0, 　
121.3, 117.6, 116.7, 116.7, 116.4, 111.8, 107.5, 103.4, 100.3, 97.1, 96.4, 84.4, 69.1, 57.2, 57.1, 35.0, 
29.7, 28.5. 
 
 (±)-6-(3,4-Dihydroxyphenyl)-12H-6,12-methanodibenzo[d,g][1,3]dioxocin-1,3-diol (11). Yield 76%. 
1H-NMR (400 MHz, CD3COCD3)  7.42 (dd, 　 J = 7.2, 1.2 Hz, 1H), 7.31 (m, 2H), 7.10 (ddd, J = 10, 
8.4,  2.0 Hz, 1H), 7.01 (d, 8.4 Hz, 1H), 6.92 (d, J = 8.4 Hz, 1H), 6.87 (ddd, J = 8.4, 7.2,  0.8 Hz, 1H), 
6.05 (d, J = 2.4 Hz, 1H), 6.02(d, J = 2.4 Hz, 1H),  4.42 (t, J = 2.8 Hz, 1H), 2.31 (t, J = 2.8 Hz, 2H). 
 
 (±)-6-(3,4-Dihydroxyphenyl)-10-nitro-12H-6,12-methanodibenzo[d,g][1,3]dioxocin-1,3-diol (12).  
Yield 80%:  1H-NMR (400 MHz, CD3COCD3)  8.30 (d, 　 J = 2.8 Hz, 1H), 8.02 (dd, J = 8.8, 2.8 Hz, 
1H), 7.25 (d, J = 2.8 Hz, 1H), 7.10 (m, 2H), 6.92 (d, J = 8.8 Hz, 1H), 6.10 (d, J = 2.8 Hz, 1H),  6.05 (d, 
J = 2.8 Hz, 1H), 4.53 (t, J = 2.8 Hz, 1H), 2.39 (t, J = 2.8 Hz, 2H); 13C-NMR (100 MHz, CD3COCD3) 
 159.9, 159.2, 156.6, 154.6, 147.4, 146.4, 143.1, 134.5, 130.8, 125.1, 124.9, 119.1, 118.4, 116.7, 　
114.9, 106.3, 101.4, 96.9, 96.3, 34.2, 28.4. 
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